Skip to Content
Merck

1801

α-Naphthyl Butyrate Solution

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.47
UNSPSC Code:
41116124
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


form

solution

Quality Level

IVD

for in vitro diagnostic use

concentration

2.4 g/L

application(s)

hematology
histology

shipped in

dry ice

storage temp.

−20°C

Application

Intended for use in the Sigma α-Butyrate Esterase kit, procedure 181B

Packaging

2.4g/L alpha-naphthyl butyrate in methanol solution with stabilizers

Disclaimer

Supply conditions do not apply to the regions and states of Brazil: North, Northeast, Mato Grosso do Sul, Mato Grosso, and Rio Grande do Sul.


signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Flam. Liq. 3 - STOT SE 1

target_organs

Eyes,Central nervous system

wgk

WGK 3



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



N F Li et al.
Cell proliferation, 40(5), 780-794 (2007-09-20)
Cell immortalization is considered to be a prerequisite status for carcinogenesis. Normal human ovarian surface epithelial (OSE) cells, which are thought to be the origin of most of human ovarian carcinomas, have a very limited lifespan in culture. Establishment of
Michael D'Angelica et al.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 24(9), 1221-1228 (2011-05-17)
Folate receptor alpha (FRα), encoded by folate receptor 1 (adult) gene, has emerged as a cancer biomarker and potential therapeutic target. In addition, its expression in tumors may offer prognostic information. The aim of this study was to assess the
Daniel J Liebertz et al.
Head & neck oncology, 2, 5-5 (2010-02-24)
Head and neck squamous cell carcinoma (HNSCC) is an aggressive and lethal malignancy. Publically available cell lines are mostly of lingual origin, or have not been carefully characterized. Detailed characterization of novel HNSCC cell lines is needed in order to